ms-553
Showing 1 - 4 of 4
Relapsed or Refractory B-cell Lymphoma, Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial in Beijing
Recruiting
- Relapsed or Refractory B-cell Lymphoma
- +6 more
- MS-553
-
Beijing, ChinaBeijing Cancer Hospital
Feb 6, 2023
Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Beijing (MS-553)
Recruiting
- Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- MS-553
-
Beijing, Xicheng District, ChinaPeking University People's Hospital
Jun 23, 2022
Diabetic Macular Edema, Macular Edema, Type 2 Diabetes With Diabetic Macular Edema Trial in Changsha, Chengdu, Shanghai (MS-553)
Recruiting
- Diabetic Macular Edema
- +4 more
- MS-553
-
Changsha, Hunan, China
- +2 more
Sep 3, 2021
Safety and PK in Healthy Volunteers Trial in Melbourne (MS-553, Placebo)
Completed
- Safety and PK in Healthy Volunteers
- MS-553
- Placebo
-
Melbourne, Victoria, AustraliaNucleus Network
Mar 14, 2016